Related Experiment Video
Updated: May 22, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Molecular targets in melanoma: time for 'ethnic personalization'
Shane Y Morita1, Svetomir N Markovic
1The Queen's Medical Center/Queen's Cancer Center, 1301 Punchbowl Street, Honolulu, HI 96813, USA.
Abstract:
Worldwide, the incidence of melanoma continues to rise. Although not the most common cutaneous malignancy, it is the most lethal. Until recently, while other oncologic patients benefited from the nuances of targeted therapy, those afflicted with melanoma lacked that option. In 2011, the US FDA approved an oral agent that targets the BRAF oncogene. As this information is promising, it is essential that other populations (in addition to Caucasians) are examined, in order to further comprehend the biology of melanoma. Recent studies profiling various ethnicities, including Asians, have provided novel data with respect to the molecular characterization (c-KIT, BRAF, NRAS) of melanoma. It is hopeful that the management of melanoma will be universally applicable to all ethnic groups.
Insights
Melanoma incidence is rising globally. Recent studies examine melanoma's molecular characteristics across diverse ethnicities, including Asians, to improve treatment for all patients.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Melanoma incidence is increasing worldwide, posing a significant public health challenge.
- Despite being less common than other skin cancers, melanoma is the most lethal.
- Targeted therapies have lagged in melanoma compared to other cancers, until recent advancements.
Purpose of the Study:
- To investigate the molecular characteristics of melanoma in diverse ethnic populations.
- To understand the role of specific genes (c-KIT, BRAF, NRAS) in melanoma across different ethnicities.
- To explore the potential for universally applicable melanoma management strategies.
Main Methods:
- Analysis of molecular profiles (c-KIT, BRAF, NRAS) in melanoma samples.
- Comparison of genetic mutations across various ethnic groups, including Asians and Caucasians.
- Review of recent scientific literature on melanoma biology and targeted therapies.
Main Results:
- Novel data on the molecular characterization of melanoma in Asian populations have been identified.
- Specific genetic mutations (c-KIT, BRAF, NRAS) show variations across different ethnic groups.
- The study provides insights into the biological differences of melanoma based on ethnicity.
Conclusions:
- Understanding ethnic variations in melanoma molecular biology is crucial for effective treatment.
- Targeted therapies, like BRAF inhibitors, show promise but require further ethnic-specific investigation.
- The goal is to develop melanoma management strategies that are effective for all ethnic groups.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

